newsfilter
← Latest News
PR Newswire·

Protalix BioTherapeutics to Participate in the 2025 BIO CEO & Investor Conference

Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of...